1.Uric Acid Is a Risk Indicator for Metabolic Syndrome-related Colorectal Adenoma: Results in a Korean Population Receiving Screening Colonoscopy.
Hyo Jin KIM ; Jee Eun KIM ; Ji Hye JUNG ; Eun Ran KIM ; Sung Noh HONG ; Dong Kyung CHANG ; Hee Jung SON ; Poong Lyul RHEE ; Jae J KIM ; Young Ho KIM
The Korean Journal of Gastroenterology 2015;66(4):202-208
BACKGROUND/AIMS: An association between serum uric acid and cancer risk has been noted over the past few decades. There is ongoing debate about whether hyperuricemia represents an independent risk factor for colorectal neoplasm. We investigated the association between serum uric acid and prevalence of colorectal adenoma considering numerous confounding factors. METHODS: A cross-sectional study was performed with individuals who underwent a routine health check-up examination, including a screening colonoscopy and blood chemistry. The association between serum uric acid and prevalence of colorectal adenoma was estimated from the results of a logistic regression analysis. RESULTS: Of the 1,066 participants, 402 had colorectal adenoma (37.7%). In univariate models, the prevalence of colorectal adenoma was higher in participants in the fourth quartile uric acid level, compared to those in the first quartile uric acid level (OR, 1.67; 95% CI, 1.17-2.42; p=0.004). However, no significant association was detected between serum uric acid and prevalence of colorectal adenoma in multiple logistic regression analysis. A number of metabolic syndrome components exhibited a strong association with the prevalence of colorectal adenoma in the multivariate model (OR, 3.46 for highest vs. lowest; 95% CI, 1.30-9.20; p=0.021). Moreover, serum uric acid was strongly associated with metabolic syndrome-associated variables, including waist circumference, fasting blood glucose, systolic blood pressure, diastolic blood pressure, triglyceride, and high-density lipoprotein. CONCLUSIONS: Uric acid is not an independent risk factor for colorectal adenoma but is a risk indicator for metabolic syndrome-related colorectal adenoma.
Adenoma/*diagnosis/epidemiology/etiology
;
Adult
;
Asian Continental Ancestry Group
;
Blood Glucose/analysis
;
Blood Pressure
;
Colonoscopy
;
Colorectal Neoplasms/*diagnosis/epidemiology/etiology
;
Cross-Sectional Studies
;
Female
;
Humans
;
Logistic Models
;
Male
;
Metabolic Syndrome X/*diagnosis
;
Middle Aged
;
Odds Ratio
;
Prevalence
;
Republic of Korea
;
Risk Factors
;
Triglycerides/blood
;
Uric Acid/*blood/urine
;
Waist Circumference
2.Helicobacter pylori Seropositivity Is Positively Associated with Colorectal Neoplasms.
Kwan Woo NAM ; Myong Ki BAEG ; Jung Hyun KWON ; Soung Hoon CHO ; Soo Jin NA ; Myung Gyu CHOI
The Korean Journal of Gastroenterology 2013;61(5):259-264
BACKGROUND/AIMS: Helicobacter pylori is a well known precursor to gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma. This study was to determine whether H. pylori was associated with colorectal neoplasms in Korean subjects undergoing routine checkup. METHODS: A total of 10,082 subjects underwent routine checkups from January 2004 to April 2005. A H. pylori IgG test and stool occult blood test were included in the routine checkup program. Colonoscopy was performed if the stool occult blood test was positive or under subject request. Patients who underwent colonoscopy and had histologically confirmed cases of colorectal neoplasms were designanted as the subject group and those without as the control group. RESULTS: Of the 10,082 subjects, 597 had full colonoscopy. The results identified 9 colorectal carcinomas and 118 adenomas. H. pylori seropositivity was identified in 6 (66%) subjects with colorectal carcinoma, 81 (68.6%) with colorectal adenoma and 248 (52.8%) controls. Subjects having colorectal neoplasms had a significantly higher H. pylori seropositivity rate compared with the controls (OR 1.94, 95% CI 1.28-2.95). This remained significant after adjusting for age, sex, body mass index, HbA1c and total cholesterol (OR 1.90, 95% CI 1.23-2.93). Patients with distal neoplasms also had a significantly higher H. pylori seroposivity rate (OR 1.88, 95% CI 1.17-3.01) which persisted after multivariate adjustment (OR 1.79, 95% CI 1.10-2.94). CONCLUSIONS: Subjects with colorectal neoplasms present an increased H. pylori seroprevalence compared with controls.
Adenoma/*diagnosis/etiology
;
Adult
;
Age Factors
;
Aged
;
Body Mass Index
;
Cholesterol/blood
;
Colonoscopy
;
Colorectal Neoplasms/*diagnosis/epidemiology/etiology
;
Female
;
Helicobacter Infections/complications/*diagnosis
;
Helicobacter pylori/*immunology
;
Hemoglobin A, Glycosylated/analysis
;
Humans
;
Immunoglobulin G/analysis
;
Male
;
Middle Aged
;
Occult Blood
;
Odds Ratio
;
Retrospective Studies
;
Risk Factors
;
Sex Factors